Atlas Trials

Determination of the Optimal Volume of Liposomal Bupivacaine in Adductor Canal Block for Knee Joint Surgery

Clinical trial NCT06942689 · RECRUITING

Trial details

NCT number
NCT06942689
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Optimal Volume of Liposomal Bupivacaine
Start date
2025-06-01
Primary completion
2027-12-31
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.